t(8;21)-Positive AML with Mutant Kit Is a Novel Therapeutic Target of Imatinib Mesylate.
Hiroya Asou(Hiroshima University), Toshiya Inaba(Hiroshima University), Taiichi Kyo(Hiroshima University)
Cited by 0
Related Papers
Fusion of the Leucine Zipper Gene <i>HLF</i> to the <i>E2A</i> Gene in Human Acute B-Lineage Leukemia
|Science|1992|298
Genomic organization, chromosomal localization, and independent expression of human cyclin D genes
|Genomics|1992|262
SLUG, a ces-1-Related Zinc Finger Transcription Factor Gene with Antiapoptotic Activity, Is a Downstream Target of the E2A-HLF Oncoprotein
|Molecular Cell|1999|208
Downregulation of Bim, a Proapoptotic Relative of Bcl-2, Is a Pivotal Step in Cytokine-Initiated Survival Signaling in Murine Hematopoietic Progenitors
|Molecular and Cellular Biology|2001|208